-
-
Nothing short of a medical miracle occurred in 2004, when a 15-year old Wisconsin girl survived rabies encephalitis following a therapeutically induced coma, using a novel combination of ketamine, ribavirin, and amantadine.
-
-
Guidelines for this years influenza season are now available, with important recommendations to hospitals and clinics.
-
There is no proven therapy for infection due to the mosquito-borne flavivirus West Nile Virus, introduced to a fully susceptible U.S. population in 1999.
-
Synopsis: A large primary care pediatric study of recurrent urinary tract infections found a 12% per year recurrence rate with risk factors being white race, age 3-5 years, and grade 4-5 vesicoureteral reflux. Antimicrobial prophylaxis did not reduce the risk for recurrence but was associated with increased risk of recurrent infection caused by resistant organisms.
-
A multicenter non-inferiority open-labeled randomized controlled trial of oral amoxicillin-clavulanate (50 mg/kg/day divided 3 times a day for 10 days) compared to initial parenteral treatment with ceftriaxone (50 mg/kg/day as a single daily dose for 3 days) followed by oral amoxicillin-clavulanate (for 7 days) for children < 6 years of age with acute pyelonephritis and no anatomic urogenital tract abnormalities was conducted from 2000 to 2004 among 502 children 1 month to 7 years of age in 28 primary care practices in northern Italy.
-
High-Dose Statin Therapy, Value for Older Adults; Simvastatin, Best for
Parkinson's Disease; Polyethylene Glycol for Chronic Constipation; FDA
Actions
-
The rabies symposium at the conference of the International Society of Travel Medicine in Vancouver, Canada, featured Drs. David Warrell, David Shlim, and Kanitta Suvansrinon.
-
This interesting report written by an ID Fellow at Walter Reed Army Medical Center (WRAMC) describes 3 cases of Q fever in deployed (or recently redeployed) soldiers serving in Iraq.